Hypros
Key Facts
| Invested since | 2018 |
| Based in | Mecklenburg-Western Pomerania |
About the company
Hypros (formerly GWA Hygiene) offers innovative digital solutions for the healthcare sector.
The focus is on relieving the burden on hospital staff and increasing patient safety. The company, which has sites in Stralsund and Lübeck, has developed an IoT platform with a wide range of applications for this purpose. These include a tracking solution for tracking devices and patients, a sensor for monitoring patients (e.g. to prevent delirium and falls) and the NosoEx hand hygiene monitoring system to prevent infections.
The interdisciplinary team of 35 employees combines expertise in hardware and software development and data analysis. Hypros promotes international sales through strong partnerships with companies such as Dräger, B. Braun and HARTMANN. Founded in 2015, the company relies on collaboration with Google and clinical partners in product development. Its customers include well-known university hospitals.
Do you want to
know more about this company?
Hypros in the news
Zum Artikel
The High-Tech Gründerfonds (HTGF) invests together with MIG Fonds and Business Angels about 2.5 million Euro in the medical technology start-up GWA Hygiene from Stralsund
More startups from Life Sciences
adivo is a biotech company generating therapeutic antibodies for companion animals, addressing the medical needs in dogs, with an upside potential for a future in care for other species. Antibody …
HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the …
GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with …
Heidelberg Epignostix is a healthcare company whose mission is to transform cancer diagnostics through data science. The company has developed novel AI-based bioinformatics algorithms with utility in cancer classification for …
Mbiomics is a Munich based microbiome startup company which was founded by Dr. Laura Figulla (CEO), Dr. Johannes Wöhrstein (CTO), and Dr. Markus Rinecker (CMO) in 2020. With its proprietary …
MYR, acquired by Gilead Sciences in 2021, developed a peptide-based, first-in-class drug to combat chronic hepatitis B and delta. The drug has been approved by the EMA for the treatment …
Humedics markets a system for bedside and instantaneous measurement of liver function. Patented device, consumables and a diagnostic drug allow an optimal market offering.
Altavo is a Dresden based medical technology startup founded in February 2021. Based on non-invasive radar sensing and AI algorithms for speech recognition and synthesis, Altavo is developing prosthetics to …
Lymphatica Medtech develops medical devices for lymphatic disease treatment. The first product, LymphoDRAIN, is the worldwide first active lymphatic bypass for the treatment of chronic lymphedema, a disabling disease affecting …
Umlaut.bio GmbH develops small molecules that are intended to be used as first-in-class therapeutics against a variety of diseases. The focus is on the “umlauts” of the genetic code – …
lino Biotech AG was incorporated as a ETH Zurich spin-out in Zürich, Switzerland, in March 2020, and is venture backed by Roche Venture Fund, High-Tech Gründerfonds and several lifescience family …
